Dr. Abreu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-2800Fax+1 214-645-8697
Summary
- Marconi Abreu, MD, is a Dallas-based endocrinologist specializing in diabetes and lipid metabolism. He completed his Internal Medicine Residency at the University of Connecticut (2004 - 2007) and his Endocrinology, Diabetes, and Metabolism Fellowship at University of Texas Southwestern Medical Center (2012 - 2015). Dr. Abreu exhibits expertise in handling conditions like diabetes mellitus, obesity-related disorders, lipid metabolism disorders, osteoporosis, and polycystic ovarian syndrome. He's widely published on these topics in reputable journals, including significant contributions on diabetes technology, medication adherence and outcomes in type 2 diabetes. Additionally, he participated in creating SIMPLE, a clinical study focusing on a Basal Insulin Titration regimen for dealing with Type 2 Diabetes.
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2012 - 2015
- University of ConnecticutResidency, Internal Medicine, 2004 - 2007
- Federal University of Bahia Faculty of MedicineClass of 2002
Certifications & Licensure
- TX State Medical License 2014 - 2026
- MA State Medical License 2008 - 2013
Clinical Trials
Publications & Presentations
PubMed
- 31 citationsEffect of medication adherence on clinical outcomes in type 2 diabetes: analysis of the SIMPLE study.Sapna Patel, Marconi Abreu, Anna Tumyan, Beverley Adams-Huet, Xilong Li
BMJ Open Diabetes Research & Care. 2019-11-01 - 25 citationsSGLT2 inhibition and heart failure-current concepts.Joaquim Silva Custodio, Andre Rodrigues Duraes, Marconi Abreu, Natália A. Rocha, Leonardo Roever
Heart Failure Reviews. 2018-05-01 - 6 citationsA randomized trial comparing the efficacy and safety of treating patients with type 2 diabetes and highly elevated HbA1c levels with basal-bolus insulin or a glucagon-...Marconi Abreu, Anna Tumyan, Ahmed Elhassan, Katherine Peicher, Olivia Papacostea
Diabetes, Obesity & Metabolism. 2019-09-01
Press Mentions
- UTSW Endocrinologists Find Paralysis Disorder May Be Underdiagnosed Among Hispanic MenMay 8th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: